Conference Call Alert - Neurobiological Technologies, Inc. (Nasdaq: NTII) RICHMOND, Calif., Nov. 5 /PRNewswire-FirstCall/ -- NTI(R) has arranged a conference call to discuss the financial results for the first quarter ended September 30, 2003. Paul Freiman, President and Chief Executive Officer, will host the call. Live Call: Date: Wednesday, November 12, 2003 Time: 10:30 a.m. ET, 9:30 a.m. CT, 7:30 a.m. PT Dial-in number: 800-289-0529 Web Cast of Call: A live web cast can be accessed by going to: http://www.shareholder.com/ntii/medialist.cfm Call Replay: A playback of the conference call will be available on November 12 at 1:30 p.m. ET through midnight on November 20th ET Replay number: (888) 203-1112 (U.S. and Canada) & (719) 457-0820 (Int'l) Replay access code: 376262 About the Company: NTI is an emerging drug development company focused on the clinical evaluation and regulatory approval of neuroscience drugs. The Company's strategy is to in-license and develop early- and later-stage drug candidates that target major medical needs and which can be rapidly commercialized. The Company's experienced management team oversees the human clinical trials necessary to establish preliminary evidence of efficacy and seeks partnerships with pharmaceutical and biotechnology companies to complete development and marketing of its product candidates. DATASOURCE: Neurobiological Technologies, Inc. CONTACT: Paul Freiman, President and CEO of Neurobiological Technologies, Inc., +1-510-262-1730, Web site: http://www.ntii.com/

Copyright